How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/staphylococcus-aureus-joint-infection.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Staphylococcus Aureus Joint Infection — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Staphylococcus Aureus Joint Infection (disease) competitive landscape: 7 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

7 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Staphylococcus Aureus Joint Infection, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Fortaz	Ceftazidime	Pai Holdings Pharm	Third-generation cephalosporin	Bacterial cell wall	1985-01-01
Augmentin 250	CLAVULANIC ACID	Dr Reddys Labs Inc	beta Lactamase Inhibitor		1984-01-01
Zinacef	CEFUROXIME	GSK	Cephalosporin Antibacterial	Carbonic anhydrase 2	1983-01-01
Bactocill In Plastic Container	OXACILLIN	Apothecon		Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2	1971-01-01
Nallpen In Plastic Container	NAFCILLIN SODIUM	Pfizer	Penicillin-class Antibacterial		1965-01-01
Nallpen In Plastic Container	NAFCILLIN	Pfizer	Penicillin-class Antibacterial		1965-01-01
Ceftazidim	Ceftazidim	Tel-Aviv Sourasky Medical Center		Penicillin-binding protein 1A, Penicillin-binding protein 1B, Peptidoglycan synthase FtsI

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 6 drugs in Staphylococcus Aureus Joint Infection
Pai Holdings Pharm · 2 drugs in Staphylococcus Aureus Joint Infection
Pfizer · 2 drugs in Staphylococcus Aureus Joint Infection
Tel-Aviv Sourasky Medical Center · 1 drug in Staphylococcus Aureus Joint Infection
GSK · 1 drug in Staphylococcus Aureus Joint Infection
Apothecon · 1 drug in Staphylococcus Aureus Joint Infection
Dr Reddys Labs Inc · 1 drug in Staphylococcus Aureus Joint Infection

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Staphylococcus Aureus Joint Infection:

Cite this brief

Drug Landscape (2026). Staphylococcus Aureus Joint Infection — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/staphylococcus-aureus-joint-infection. Accessed 2026-06-10.

Staphylococcus Aureus Joint Infection full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing